Medpace Reports Q2 2026 Revenue and Net Income
Medpace Holdings reported $707.3 million in Q2 2026 revenue, up 17.2% year-over-year, alongside $795.7 million in net new business awards, showcasing the contract research organization's strong financial momentum.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day